No Data
No Data
B.Riley Financial Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $24
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability
While Institutions Invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Benefited From Last Week's 16% Gain, Individual Investors Stood to Gain the Most
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $27
Eton Sells Ex-U.S. Rights for Hormone Disorder Therapy to Esteve Pharma